Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-1773-2019 — CardioCommand, Inc. Transesophageal Cardiac Pacing and Recording System, Model 7A, REF 0101 - Product Usage: Indications for Use: - Temporary left atrial pacing to treat bradycardia, hypotension or AV junctional rhythm - Acceleration of heart rate as an alternative to exercise or drugs during diagno

U.S. FDA — Device Enforcement · United States · 2019-05-10 · Class III

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →

Agency: U.S. FDA — Device Enforcement
Recall identifier: Z-1773-2019
Date of alert: 2019-05-10
Country / jurisdiction: United States
Risk level: Class III
Risk type: recall
Brand: Cardiocommand Inc.
Product category: device
Product type: Devices

Reported risk: Possible corrosion of the battery contact(s).

Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.

Related